Xu D - Search Results

1

Clinical Utility of ¹⁸F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience.

Liu A, Zhang M, Huang H, Zhang C, Ruan X, Lin W, Li B, Chen L, Xu D. Liu A, et al. Among authors: xu d. Front Oncol. 2021 Feb 11;10:612701. doi: 10.3389/fonc.2020.612701. eCollection 2020. Front Oncol. 2021. PMID: 33680933 Free PMC article.

2

Transrectal sonoelastography in the detection of prostate cancers: a meta-analysis.

Teng J, Chen M, Gao Y, Yao Y, Chen L, Xu D. Teng J, et al. Among authors: xu d. BJU Int. 2012 Dec;110(11 Pt B):E614-20. doi: 10.1111/j.1464-410X.2012.11344.x. Epub 2012 Jul 12. BJU Int. 2012. PMID: 22788672 Review.

3

MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.

Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L, Liu Y, Gao Y, Xu D, Wang Q. Qu F, et al. Among authors: xu d. Mol Cell Biochem. 2013 May;377(1-2):121-30. doi: 10.1007/s11010-013-1576-z. Epub 2013 Feb 17. Mol Cell Biochem. 2013. PMID: 23417242

4

Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.

Zhang X, Zhang D, Qu F, Hong Y, Cao J, Pan X, Li L, Huang Y, Huang H, Yin L, Chen L, Ren J, Wang Z, Xu D, Cui X. Zhang X, et al. Among authors: xu d. Mol Cell Biochem. 2014 Nov;396(1-2):1-8. doi: 10.1007/s11010-014-2126-z. Epub 2014 Aug 29. Mol Cell Biochem. 2014. PMID: 25169742

5

Positive nin one binding protein expression predicts poor outcome in prostate cancer.

Chen J, Wang J, Cui X, Liu Y, Yin L, Li Y, Chen L, Xu D, Gao Y. Chen J, et al. Among authors: xu d. Mol Med Rep. 2015 Apr;11(4):2671-6. doi: 10.3892/mmr.2014.3066. Epub 2014 Dec 9. Mol Med Rep. 2015. PMID: 25503472

6

Sunitinib dosing schedule 2/1 improves tolerability, efficacy, and health-related quality of life in Chinese patients with metastatic renal cell carcinoma.

Pan X, Huang H, Huang Y, Liu B, Cui X, Gan S, Ye J, Xu D, Chen L, Zhou Q, Li L, Hong Y. Pan X, et al. Among authors: xu d. Urol Oncol. 2015 Jun;33(6):268.e9-15. doi: 10.1016/j.urolonc.2015.03.008. Epub 2015 Apr 8. Urol Oncol. 2015. PMID: 25863944

7

The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Gao Y, Teng J, Hong Y, Qu F, Ren J, Li L, Pan X, Chen L, Yin L, Xu D, Cui X. Gao Y, et al. Among authors: xu d. Med Oncol. 2015 Jul;32(7):518. doi: 10.1007/s12032-015-0518-x. Epub 2015 Jun 3. Med Oncol. 2015. PMID: 26036682

8

Selection of personalized laparoscopic partial nephrectomy based on tumor characteristics: A preliminary study in a single center.

Chen L, Pan X, Cui X, Zhao Q, Gao Y, Yin L, Wang L, Xu D. Chen L, et al. Among authors: xu d. Int J Surg. 2015 Nov;23(Pt A):46-51. doi: 10.1016/j.ijsu.2015.09.025. Epub 2015 Sep 15. Int J Surg. 2015. PMID: 26384839 Free article.

9

Quality-of-life outcomes and unmet needs between ileal conduit and orthotopic ileal neobladder after radical cystectomy in a Chinese population: a 2-to-1 matched-pair analysis.

Huang Y, Pan X, Zhou Q, Huang H, Li L, Cui X, Wang G, Jizhong R, Yin L, Xu D, Hong Y. Huang Y, et al. Among authors: xu d. BMC Urol. 2015 Nov 27;15:117. doi: 10.1186/s12894-015-0113-7. BMC Urol. 2015. PMID: 26610351 Free PMC article.

10

Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.

Ren J, Pan X, Li L, Huang Y, Huang H, Gao Y, Xu H, Qu F, Chen L, Wang L, Hong Y, Cui X, Xu D. Ren J, et al. Among authors: xu d, xu h. Chem Biol Drug Des. 2016 May;87(5):704-13. doi: 10.1111/cbdd.12704. Epub 2016 Jan 17. Chem Biol Drug Des. 2016. PMID: 26669804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,580 results

Search Page

Filters